Cargando…

Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer

BACKGROUND: Transurethral resection of the bladder tumor with or without adjuvant intravesical instillation (IVI) has been the standard treatment for non-muscle-invasive bladder cancer (NMIBC), whereas a high percentage of patients still experience local tumor recurrence and disease progression afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Li, Deng, Xiaobin, Xia, Wentao, Wang, Kun, Zhang, Yang, Zhang, Yan, Shao, Xianfeng, Wang, Junqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706099/ https://www.ncbi.nlm.nih.gov/pubmed/36458001 http://dx.doi.org/10.3389/fimmu.2022.1070043

Ejemplares similares

Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ding, Li, et al.
Publicado: (2023)

Preoperative systemic immune‐inflammation index as a significant prognostic factor after TURBT in patients with non‐muscle‐invasive bladder cancer: A retrospective study based on propensity score matching analysis
por: Ding, Li, et al.
Publicado: (2022)

Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ
por: Cui, Jianfeng, et al.
Publicado: (2017)

Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma
por: Yang, Yao-Cheng, et al.
Publicado: (2021)

AB048. Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle invasive bladder cancer without carcinoma in situ
por: Cui, Jianfeng, et al.
Publicado: (2017)

Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation
por: Cheng, Yuan, et al.
Publicado: (2020)

Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score
por: Zhao, Liwei, et al.
Publicado: (2021)

A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2019)

An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer
por: Li, Longchao, et al.
Publicado: (2023)

Development of a MRI-Based Radiomics Nomogram for Prediction of Response of Patients With Muscle-Invasive Bladder Cancer to Neoadjuvant Chemotherapy
por: Zhang, Xinxin, et al.
Publicado: (2022)

Development and external validation of a nomogram for predicting postoperative pneumonia in aneurysmal subarachnoid hemorrhage
por: Jin, Xiao, et al.
Publicado: (2023)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection
por: Zhang, Yanfang, et al.
Publicado: (2022)

Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy
por: Hu, Bing, et al.
Publicado: (2023)

Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
por: Zhang, Jianglei, et al.
Publicado: (2021)

Deceptive Muscle Invasive Bladder Cancer Recurrence With Benign Biopsy Foci After Bladder Sparing Treatment
por: Xu, Chuanliang, et al.
Publicado: (2015)

A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients
por: Zhang, Xiaolong, et al.
Publicado: (2020)

Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing
por: Zhang, Shufang, et al.
Publicado: (2014)

The relationship between inflammatory response markers and the prognosis of non-muscle invasive bladder cancer and the development of a nomogram model
por: Yi, Xinping, et al.
Publicado: (2023)

Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer
por: Zhang, Jinghua, et al.
Publicado: (2021)

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer
por: Yasui, Masato, et al.
Publicado: (2019)

Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
por: Lammers, Rianne J. M., et al.
Publicado: (2015)

A Myeloid Signature-Based Nomogram Predicts the Postoperative Recurrence of Intrahepatic Cholangiocarcinoma
por: Liang, Jing, et al.
Publicado: (2021)

A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma
por: Wang, Tao, et al.
Publicado: (2021)

Analysis and prediction of postoperative recurrence of unilateral upper ureteral calculi in 243 cases (nomogram)
por: Zhou, Qi, et al.
Publicado: (2023)

Initial experience with surrounding en bloc transurethral resection of bladder tumor and simultaneous intravesical treating for non-muscle invasive bladder cancer
por: Teng, Lichen, et al.
Publicado: (2022)

A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
por: Zhang, Zehan, et al.
Publicado: (2022)

Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection
por: Wang, Tao, et al.
Publicado: (2020)

Development of an innovative nomogram of risk factors to predict postoperative recurrence of gastrointestinal stromal tumors
por: Guan, Shi-Hao, et al.
Publicado: (2022)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis
por: Ge, Peng, et al.
Publicado: (2018)

Single postoperative instillation for non-muscle invasive bladder cancer: are there still any indication?
por: Zamboni, Stefania, et al.
Publicado: (2019)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
por: Ma, Chengquan, et al.
Publicado: (2016)

A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy
por: Zhan, Xiangpeng, et al.
Publicado: (2022)

Clinical application of drug sensitive gene detection in postoperative instillation for non-muscle invasive bladder cancer
por: Wang, Zhenlong, et al.
Publicado: (2020)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence
por: Yu, Seong Hyeon, et al.
Publicado: (2023)

External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence
por: Lee, Byung Min, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_do1t4r2d5kf8lheavonfo5nij2